Korean Journal of Environmental Biology (환경생물)

Korean Society of Environmental Biology (한국환경생물학회)
권호 표지

Change in the Expression of Occludin, a Gene for Blood-Brain Barrier by Phytoestrogens in Hippocampus of Rat Model for Menopause

폐경기모델 백서 해마에서 식물성 에스트로젠에 의한 뇌-혈액장벽 유전자 occludin 발현의 변화

  • Published : 2006.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

To elucidate the effect of phytoestrogens on the prevention of neurodegenerative disease in postmenopausal women, the expression of occludin which build up the blood-brain barrier was examined in hippocampus following oral administration of estrogen (E2), genistein, diadzein or combination of genistein and diadzein in ovariectomized (OVX) female rats. E2 significantly increased occludin mRNA level in OVX rat hippocampus, suggesting that estrogen is a physiological regulator for structural integrity of the blood-brain barrier in hippocampus. Following isoflavone diet for 4 weeks, there was significant increase in occludin mRNA level in hippocampus, suggesting that isoflavone diet may be effective for protection of structural integrity of blood-brain barrier in hippocampus from degenerative changes in estrogen deficiency.

폐경기 여성은 동령 남성보다 퇴행적 뇌질환의 빈도가 유의적으로 높으며 이를 예방개선하기 위한 목적으로 에스트로젠 대체요법이 시행되고 있으나 유방암과 자궁암 유발 위험성이 제시되고 있어 콩류 등에 다량 함유되어 있는 phytoestrogen류인 isoflavone을 이용한 대체요법 개발이 활발하다. 밀착결합에 의해 제공되는 혈액-뇌확산장벽은 뇌의 항상성 조절에 중요한 역할이 있으며 다양한 뇌질환에서 변형이 일어난다. 본 연구는 난소절제 백서 모델에서 폐경기 여성의 퇴행적 뇌질환의 원인으로 혈액-뇌 확산장벽의 변형과 isoflavone의 효과를 검색하였다. 8주령 암컷 백서를 난소절제한 후 4주간 estrogen또는 isoflavone을 투여한 후 해마조직에서 밀착결합 유전자의 일종인 occludin발현을 조사하였다. E2는 occludin mRNA발현을 유의하게 증가시켰으며, genistein, diadzein등의 isoflavone투여 시 occludin mRNA발현이 유의적으로 증가하였다. Occludin은 폐경기 여성 호발성 퇴행성 뇌질환의 병인유전자 가능성이 제시되며 isoflavone은 occludin의 발현을 증가시켜 에스트로젠 결핍에 따른 혈액-뇌 확산장벽의 변형을 예방하는 효과가 있는 것으로 사료된다.

Keywords

References

  1. Ahn HS and MC Gye. 2004. Endocrine-mimicking phytoestrogens: heath effects and signaling. Korean J. Environ. Biol. 22:479-486
  2. Ardelt AA, LD McCullough, KS Korach, MM Wang, DH Munzenmaier and PD Hum. 2005. Estradiol regulates angiopoietin-I mRNA expression through estrogen receptor-alpha in a rodent experimental stroke model. Stroke 36:337-341 https://doi.org/10.1161/01.STR.0000153795.38388.72
  3. Bake Sand F Sohrabji. 2004. 17beta-estradiol differentially regulates blood-brain barrier permeability in young and aging female rats. Endocrinology 145:5471-5475 https://doi.org/10.1210/en.2004-0984
  4. Behl C, M Widmann, T Trapp and F Holsboer. 1995. 17betaestradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216:473-482 https://doi.org/10.1006/bbrc.1995.2647
  5. Bolton SJ, DC Anthony and VH Perry. 1998. Loss of the tight junction proteins occludin and zonula occludens-l from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience 86: 1245-1257 https://doi.org/10.1016/S0306-4522(98)00058-X
  6. Collins-Burow BM, ME Burow, BN Duong and JA McLachlan. 2000. Estrogenic and anti estrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms. Nutr. Cancer 38:229-244 https://doi.org/10.1207/S15327914NC382_13
  7. Fritz W A, IE Eltoum, MS Cotroneo and CA Lamartiniere. 2002. Genistein alters growth but is not toxic to the rat prostate. J. Nutr. 132:3007-3011
  8. Fritz WA, J Wang and CA Lamartiniere. 1998. Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis 19: 2151-2158 https://doi.org/10.1093/carcin/19.12.2151
  9. Gibbs RB. 1998. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function. Exp. Neurol. 151:289-302 https://doi.org/10.1006/exnr.1998.6789
  10. Harris DM, E Besselink, SM Henning, VL Go and D Heber. 2005. Phytoestrogens induce differential estrogen receptor alpha or beta mediated responses in transfected breast cancer cells. Exp. Biol. Med. 230:558-568 https://doi.org/10.1177/153537020523000807
  11. Hatoya S, R Torii, D Kumagai, K Sugiura, N Kawate, T Hiromichi, T Sawada and T Inaba. 2003. Expression of estrogen receptor a and b genes in the mediobasal hypothalamus, pituitary and ovary during the canine estrous cycle. Neurosci. Lett. 347:131-135 https://doi.org/10.1016/S0304-3940(03)00639-6
  12. Horn-Ross PL, KJ Hoggatt and MM Lee. 2002. Phytoestrogens and thyroid cancer risk: the San Francisco Bay Area thyroid cancer study. Cancer Epidemiol. Biomarkers Prev. 11 :43-49
  13. Kim H, H Xia, L Li and J Gewin. 2000. Attenuation of neurodegeneration-relevant modifications of brain proteins by dietary soy. Biofactors 12:243-250 https://doi.org/10.1002/biof.5520120137
  14. Kniesel U and H Wolburg. 2000. Tight junctions of the bloodbrain barrier. Cell Mol Neurobiol. 20:57-76 https://doi.org/10.1023/A:1006995910836
  15. Kuiper GG, B Carlsson, K Grandien, E Enmark, J haggblad S Nilsson and JA Gustafsson. 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta $\beta$. Endocrinology 138:863-870 https://doi.org/10.1210/en.138.3.863
  16. Kuiper GG, JG Lemmen, B Carlsson, JC Corton, SH Safe, PT van der Saag, B van der Burg and J-A Gustafsson. 1998. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor$\beta$. Endocrinology 139:4252-4263 https://doi.org/10.1210/en.139.10.4252
  17. McCann SE, KB Moysich, JL Freudenheim, CB Ambrosone and PG Shields. 2002. The risk of breast cancer associated with is dietary lignans differs by CYP17 genotype in women. J. Nutr. 132:3036-3041
  18. McCann SE, JL Freudenheim, JR Marshall and S Graham. 2003. Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. J. Nutr. 133:1937-1942
  19. Mentor-Marcel R, CA Lamartiniere, I-E Eltoum, NM Greenberg and A Elgavish. 2001. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res. 61:6777-6782
  20. Murrill W, N Brown, J Zhang, P Manzolillo, S Barnes and CA Lamartiniere. 1996. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17: 1451-1457 https://doi.org/10.1093/carcin/17.7.1451
  21. Molsa PK, RJ Marttila and UK Rinne. 1982. Epidemiology of dementia in a Finnish population. Acta Neurol. Scand. 65: 541-552 https://doi.org/10.1111/j.1600-0404.1982.tb03109.x
  22. Nilsson Sand JA Gustafsson. 2000. Estrogen receptor trans-cription and transactivation: Basic aspects of estrogen action. Breast Cancer Res. 2:360-366 https://doi.org/10.1186/bcr81
  23. Nilsson Sand JA Gustafsson. 2002. Biological role of estrogen and estrogen receptors. Crit. Rev. Biochem. Mol. Biol. 37:1-28 https://doi.org/10.1080/10409230290771438
  24. Roux KJ, SA Amici and L Notterpek. 2004. The ternporospatial expression of peripheral myelin protein 22 at the developing blood-nerve and blood-brain barriers. J Comp Neurol. 474:578-588 https://doi.org/10.1002/cne.20154
  25. Rubin LL and JM Staddon. 1999. The cell biology of the blood -brain barrier. Ann. Rev. Neurosci. 22: 11-28 https://doi.org/10.1146/annurev.neuro.22.1.11
  26. Savaskan E, G Olivieri, F Meier, R Ravid and F Muller-Spahn, 2001. Hippocampal estrogen beta-receptor immunoreactivity is increased in Alzheimer's disease. Brain Res. 908: 113-119 https://doi.org/10.1016/S0006-8993(01)02610-5
  27. Schonknecht P, J Pantel, K Klinga, M Jensen, T Hartmann, B Salbach and J Schroder. 2001. Reduced cerebrospinal fluid estradiol levels are associated with increased beta-amyloid levels in female patients with Alzheimer's disease. NeuroSci. Lett. 307: 122-124 https://doi.org/10.1016/S0304-3940(01)01896-1
  28. Toran-Allerand CD, M Singh and G Jr Setalo. 1999. Novel mechanisms of estrogen action in the brain: new players in an old story. Front Neuroendocrinol. 20:97-121 https://doi.org/10.1006/frne.1999.0177
  29. Tsukita Sand M Furuse. 1998. Overcoming barriers in the study of tight junction functions: from occludin to claudin. Genes Cells 3:569-573 https://doi.org/10.1046/j.1365-2443.1998.00212.x
  30. Weisz A and R Rosales. 1990. Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and AP-1 transcription factor. Nucleic Acids Res. 18:5097-5106 https://doi.org/10.1093/nar/18.17.5097
  31. Ye L, TA Martin, C Parr, GM Harrison, RE Mansel and WG Jiang. 2003. Biphasic effects of 17-beta-estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells. J. Cell Physiol. 196:362-369 https://doi.org/10.1002/jcp.10315
  32. Zeng R, X Li and GI Gorodeski. 2004. Estrogen abrogates transcervical tight junctional resistance by acceleration of occludin modulation. J. Clin. Endocrinol. Metab. 89:5145-5155 https://doi.org/10.1210/jc.2004-0823